Literature DB >> 22166463

Impulse control disorders in Parkinson's disease.

Dolores Vilas1, Claustre Pont-Sunyer, Eduardo Tolosa.   

Abstract

Impulse control disorders (ICDs), a group of complex behavioral disorders, occur more commonly in Parkinson's disease (PD) patients than in the general population, with a reported prevalence up to 13.6% in some studies. The most common ICDs reported are pathological gambling (PG), hypersexuality (HS), compulsive shopping and compulsive eating. More than a quarter of the patients with ICDs have 2 or more behavioral addictions. These abnormal behaviors impair activities of daily living and have a negative impact on quality of life of patients and their families. As with many other non motor symptoms in PD, ICDs are frequently under-reported by patients and caregivers and may be under-recognized by the treating physicians. Treatment with dopamine agonists (DA) is the main risk factor for developing ICDs, and stimulation of mesolimbic D3 receptors by DA is thought to underlie their development. The DA effect seems to be a class effect and not specific for any DA. Levodopa can also induce ICDs but much less so than the DAs. The management of ICDs in PD is complex. Modifications in dopaminergic drug treatment are frequently necessary. In some cases alternative therapies such as atypical antipsychotics, antidepressants or deep brain stimulation if motor symptoms become incapacitating after adjustment of dopamine replacement therapy should be considered.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22166463     DOI: 10.1016/S1353-8020(11)70026-8

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  22 in total

1.  Clozapine use for refractory impulse control disorders in Parkinson's disease: a case report.

Authors:  Nicolas A Bonfils; Amine Benyamina; Henri-Jean Aubin; Amandine Luquiens
Journal:  Psychopharmacology (Berl)       Date:  2015-08-21       Impact factor: 4.530

Review 2.  Sex, drugs and Parkinson's disease.

Authors:  Mwiza Ushe; Joel S Perlmutter
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

3.  Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-12

4.  Impulse control disorders in Parkinson's disease: background and update on prevention and management.

Authors:  Robert F Leeman; Benjamin E Billingsley; Marc N Potenza
Journal:  Neurodegener Dis Manag       Date:  2012-08-01

5.  Part 2: Introduction to the Pharmacotherapy of Parkinson's Disease, With a Focus on the Use of Dopaminergic Agents.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-09

6.  Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry.

Authors:  Trevor Archer; Marlene Oscar-Berman; Kenneth Blum; Mark Gold
Journal:  J Genet Syndr Gene Ther       Date:  2012-05-30

7.  Available and future treatments for atypical parkinsonism. A systematic review.

Authors:  Davide Vito Moretti
Journal:  CNS Neurosci Ther       Date:  2018-10-07       Impact factor: 5.243

Review 8.  Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?

Authors:  Michael S Okun; Daniel Weintraub
Journal:  Mov Disord       Date:  2013-11-15       Impact factor: 10.338

Review 9.  Neuroimaging in Parkinson disease: from research setting to clinical practice.

Authors:  Marios Politis
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

10.  Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa.

Authors:  Kristin M Pearson-Fuhrhop; Brian Minton; Daniel Acevedo; Babak Shahbaba; Steven C Cramer
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.